SYS-CON MEDIA Authors: Lori MacVittie, RealWire News Distribution, Cynthia Dunlop, Mark O'Neill, Kevin Benedict

News Feed Item

ZELTIQ(R) Aesthetics to Exhibit at IMCAS 2014

Exclusive Symposium to Focus on CoolSculpting(R) Procedure

PLEASANTON, CA -- (Marketwired) -- 01/31/14 -- ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it is showcasing its CoolSculpting system at the International Master Course on Aging Skin (IMCAS) Annual Meeting in Paris, 31 January to 2 February, 2014. The CoolSculpting procedure is a non-invasive, clinically proven procedure designed to selectively reduce fat in problem areas using a patented cooling technology.

Dr. Klaus Hoffmann, on staff with St. Josef Hospital and Ruhr University in Bochum, Germany, will be speaking about the safety, efficacy and value that CoolSculpting treatments can bring to physicians and their patients during symposium #28, "Don't Settle for Less than the Absolute Best." Symposium #28 takes place on Sunday, 2 February, 9:30-10:30 a.m., in Room 5. Dr. Hoffmann will be joined by business analyst Ralph Brinkmann.

WHAT:
ZELTIQ Aesthetics
Booth A5

WHEN:
Friday, 31 January, 2014, 8 a.m. to 7 p.m.
Saturday, 1 February, 2014, 8 a.m. to 6:30 p.m.
Sunday, 2 February, 2014, 8 a.m. to 1 p.m.

WHERE:
International Master Course on Aging Skin (IMCAS) Annual Meeting 2014
Le Palais des Congrès
2 Place de la Porte Maillot
75017 Paris - France

About ZELTIQ® Aesthetics, Inc.
ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting System, is designed to selectively reduce stubborn fat that may not respond to diet or exercise. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.

In the U.S. and Taiwan, non-invasive fat reduction is cleared only for the flank (love handle) and abdomen. The CoolSculpting procedure for non-invasive fat reduction is available worldwide. CoolSculpting, the CoolSculpting logo and the Snowflake design are registered trademarks of ZELTIQ Aesthetics, Inc. ©2014 All rights reserved. The products described in this document may be covered by U.S. Patent 7,367,341. Other patents and patent applications pending worldwide. IC1554-A

Media Contact
Nathalie d'Amico
Nat'Communication for ZELTIQ
+ 33 6 08 57 82 11
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.